Oclacitinib Treatment and Surgical Management in a Case of Periocular Eosinophilic Furunculosis and Vasculitis with Secondary Eyelid Fusion in a Diabetic Cat

    June 2025 in “ Veterinary Sciences
    Sarah Ehling, A Marx, Claudia Busse, Andreas Beineke, Andrea Vanessa Volk
    TLDR Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.
    A 10-year-old diabetic British Shorthair cat presented with severe facial and periocular skin issues, including swelling, erythema, alopecia, and ulcerations. Histopathology identified eosinophilic furunculosis and vasculitis. Initial glucocorticoid treatment improved symptoms but increased glucose levels, making systemic glucocorticoids and ciclosporin unsuitable. Instead, oclacitinib was used off-label, leading to rapid symptom remission with no recurrence for 17 months. Surgical intervention was required to correct secondary eyelid fusion due to cicatrization, restoring full eyelid function.
    Discuss this study in the Community →

    Related Community Posts Join

    0 / 0 results
    — no results

    Similar Research

    5 / 39 results